Literature DB >> 7801525

Emerging chloramphenicol resistance in Staphylococcus lentus from mink following chloramphenicol treatment: characterisation of the resistance genes.

S Schwarz1.   

Abstract

A total of 26 staphylococcal strains isolated from mink with urinary tract infections as well as from the environment of the mink were examined for antibiotic resistance and prevalence of plasmids mediating resistance to the antibiotics applied for prophylactic or therapeutic purposes. Chloramphenicol resistance (Cmr) which occurred in fourteen of the eighteen Staphylococcus lentus strains, but in none of the Staphylococcus intermedius and Staphylococcus xylosus strains, was shown to be mediated by small plasmids of 3.6 to 4.6 kb. On the basis of restriction endonuclease mapping and hybridization experiments, four different types of Cmr plasmids, designated pSCS14-17, could be distinguished. All these plasmids conferred Cmr by encoding the Cm-inactivating enzyme chloramphenicol acetyltransferase (CAT). In all four types of Cmr plasmids from S. lentus, the expression of the cat gene was inducible with Cm, as demonstrated by enzymatic assay and polyacrylamide gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7801525     DOI: 10.1016/0378-1135(94)90135-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  2 in total

1.  Macrolide-lincosamide-streptogramin B resistance in Staphylococcus lentus results from the integration of part of a transposon into a small plasmid.

Authors:  C Werckenthin; S Schwarz; K Dyke
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  Prevalence, species distribution and antimicrobial resistance patterns of methicillin-resistant staphylococci in Lithuanian pet animals.

Authors:  Modestas Ruzauskas; Natacha Couto; Sigita Kerziene; Rita Siugzdiniene; Irena Klimiene; Marius Virgailis; Constança Pomba
Journal:  Acta Vet Scand       Date:  2015-06-02       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.